CBS 2019
CBSMD教育中心
English

肺动脉高压

科研文章

荐读文献

Bridging the Gap Between Epigenetic and Genetic in PAH Pulmonary Hypertension Caused by a Coconut Left Atrium Immunotherapy of Endothelin-1 Receptor Type A for Pulmonary Arterial Hypertension Left main coronary artery compression in pulmonary hypertension Pulmonary Artery Denervation: An Alternative Therapy for Pulmonary Hypertension Intravascular Ultrasound Pulmonary Artery Denervation to Treat Pulmonary Arterial Hypertension (TROPHY1): Multicenter, Early Feasibility Study Update on chronic thromboembolic pulmonary hypertension Updated clinical classification of pulmonary hypertension Risk Stratification in PAH Noninvasive Screening for Pulmonary Hypertension by Exercise Testing in Congenital Heart Disease
|<< 1 2 3 4 5 6 7 8 >>|

Review Article2013 Dec 24;62(25 Suppl):D34-41.

JOURNAL：J Am Coll Cardiol. Article Link

Updated clinical classification of pulmonary hypertension

Simonneau G, Gatzoulis MA, Adatia I et al. Keywords: CHD; HAART; HIV; IFN; PAH; PAP; PH; PH due to chronic lung diseases; PH due to left heart disease; POPH; PPHN; PVR; SCD; Sch-PAH; TGF; TKI; chronic thromboembolic pulmonary hypertension; congenital heart disease; highly active antiretroviral therapy; human immunodeficiency virus; interferon; persistent pulmonary hypertension of the newborn; portopulmonary hypertension; pulmonary arterial hypertension; pulmonary arterial pressure; pulmonary hypertension; pulmonary vascular resistance; schistosomiasis-associated PAH; sickle cell disease; tumor growth factor; tyrosine kinase inhibitor

FULL TEXT PDF

>CBS CBS 2019

> CBS 2019

> CBS 2019 注册

> CBS 2019 会议日程

> CBS 2019 学术征集

> CBS 2019 热点

 CBSMD

> CBSMD 网站注册

> 教育中心

> 荐读文献

> Top 10 阅读文献

> 文献导读
CBS 2019 CBS 2019 主席团 教育中心 科研动态
Copyright ⓒ CBS MD Nanjing China. All rights reserved. 京ICP备16025898号-11
联系我们| Top